Search alternatives:
binding » findings (Expand Search), building (Expand Search)
Showing 161 - 180 results of 748 for search 'binding interventions', query time: 0.09s Refine Results
  1. 161

    The Detoxifying Effects of Spirulina in Promoting Liver Health and Heavy Metal Elimination – A Review by Sunil Namdeo Thitame, Ashwini Ashok Aher, Viddyasagar Mopagar

    Published 2025-05-01
    “…Furthermore, spirulina’s chelating agents support the binding and excretion of heavy metals, such as lead, mercury, and cadmium, from the body. …”
    Get full text
    Article
  2. 162

    Radiation Synovectomy: An Enticing Treatment Option for Inflammatory Joint Pain by Ashutosh Dash, Tapas Das

    Published 2025-01-01
    “…The selection of an optimal radionuclide hinges on critical nuclear and chemical properties, ensuring effective binding to microparticles and delivering favorable clinical outcomes. …”
    Get full text
    Article
  3. 163

    Prediction of Preterm Birth: Maternal Characteristics, Ultrasound Markers, and Biomarkers: An Updated Overview by Zeynep Asli Oskovi Kaplan, A. Seval Ozgu-Erdinc

    Published 2018-01-01
    “…Bedside tests have also been developed for detecting markers like fetal fibronectin, insulin-like growth factor binding protein-1 (IGFBP-1), interleukin-6, and placental alpha-macroglobulin-1. …”
    Get full text
    Article
  4. 164

    Economical epidemiology, pathological populations, and the long history of the Demographic and Health Survey by John Nott

    Published 2025-12-01
    “…Focussing initially on questions of human capital, cross-sectional surveys have tended to promote and promise efficiency in terms of medical research and interventions, thereby reducing the need for extensive and expensive infrastructure. …”
    Get full text
    Article
  5. 165

    Clinical significance of lncRNA PAX8-AS1 and miR-96-5p in non-small cell lung cancer by Qiaoling Ying, Hui Xu, Xiaojiao Wu, Hang Fang, Jingjing Shi, Hangcheng Pan

    Published 2025-07-01
    “…The goal is to provide a reference for improving adverse outcomes in NSCLC and developing effective early interventions in the clinic. Methods A total of 112 NSCLC patients and 70 healthy volunteers were recruited as the study subjects. …”
    Get full text
    Article
  6. 166

    Altered network connectivity and global efficiency in tourette syndrome: insights into sensorimotor integration by Julia Schmidgen, Theresa Valentine Heinen, Felix Schmitt, Kerstin Konrad, Stephan Bender

    Published 2025-01-01
    “…This study investigates the role of theta connectivity in network mechanisms related to perception–action-binding, sensorimotor integration, and motor preparation in children with Tourette’s Syndrome (TS). …”
    Get full text
    Article
  7. 167

    Natural AI-based drug designing by modification of ascorbic acid and curcumin to combat buprofezin toxicity by using molecular dynamics study by Haleema Sadia, Irfan Zia Qureshi, Muhammad Naveed, Tariq Aziz, Metab Alharbi, Abdullah F. Alasmari, Thamer H. Albekairi

    Published 2024-11-01
    “…Docking experiments disclosed that the interaction of CAT with the ascorbic acid AI-derived drug demonstrated a binding energy of -7.1 kcal/mol, signifying a robust interaction, while the complex of IL-1B with the curcumin AI-derived drug exhibited a binding energy of -7.3 kcal/mol. …”
    Get full text
    Article
  8. 168

    The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Yuanyuan Guan, Dongjun Wang, Huaien Bu, Tieniu Zhao, Hongwu Wang

    Published 2020-01-01
    “…Compared with control interventions, metformin appears to be an effective intervention for overweight women with PCOS.…”
    Get full text
    Article
  9. 169

    Progress in research on nutrition, neuroinflammation and dopaminergic alterations in Tic disorders by Lu Bai, Mei Jin, Qi Zhang, Suzhen Sun

    Published 2025-05-01
    “…Neuroimaging studies have shown increased dopamine transporter binding and decreased serotonin levels in patients with TD. …”
    Get full text
    Article
  10. 170

    The regulatory variant rs1950834 confers the risk of depressive disorder by reducing LRFN5 expression by Di Luan, Yifan Li, Aini Zhang, Qingqing Bai, Te Zhao, Xi Chen, Xinglun Dang, Junyang Wang, Shaolei Jiang, Yun Sun, Yingjie Zhu, Yan Kong, Xiong-Jian Luo, Zhijun Zhang

    Published 2025-05-01
    “…Conclusions These findings reveal that the functional risk single nucleotide polymorphism rs1950834 at 14q21.1 regulates LRNN5 expression and function in NAc, providing a novel perspective for molecular diagnosis and targeted interventions of MDD. Graphical Abstract The risk allele (A) of rs1950834 reduced the binding affinity to transcription factors POLR2A and the RAD21, leading to decreased expression of LRFN5. …”
    Get full text
    Article
  11. 171

    A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B by Hongyin Fan, Liqun Zhao, Weiwei Wang, Feng Yu, Haiming Jing, Yun Yang, Xiaoli Zhang, Zhuo Zhao, Qiang Gou, Weijun Zhang, Quanming Zou, Jinyong Zhang, Hao Zeng

    Published 2024-12-01
    “…Staphylococcal Enterotoxin B (SEB), produced by Staphylococcus aureus (S. aureus), is a powerful superantigen that induces severe immune disruption and toxic shock syndrome (TSS) upon binding to MHC-II and TCR. Despite its significant impact on the pathogenesis of S. aureus, there are currently no specific therapeutic interventions available to counteract the mechanism of action exerted by this toxin. …”
    Get full text
    Article
  12. 172

    Drug resistance in parasites: A review of mechanisms, drivers, and mitigation strategies by Jan Clyden Tenorio

    Published 2025-08-01
    “…Resistance is often attributed to mutations in target proteins, altering their binding and efficacy. Other factors contributing to resistance include increased drug exposure due to self-medication, genetic diversity of parasites, and environmental factors like climate change. …”
    Get full text
    Article
  13. 173

    Monoclonal Antibodies for Treatment of COVID-19: An Updated Review of Current Evidence by Saurabh Nimesh, Pratibha Kumari, Rohit Kumar, Gosiya Gosiya, Md. Quamuddin, Md. Iftekhar Ahmad

    Published 2024-11-01
    “… The emergence of COVID-19 in December 2019 spurred a global effort to develop effective medical interventions. Therapeutic monoclonal antibodies (mAbs) have emerged as a promising strategy to combat the SARS-CoV-2 virus. …”
    Get full text
    Article
  14. 174

    Cytoskeletal Proteins and Alzheimer’s Disease Pathogenesis: Focusing on the Interplay with Tau Pathology by Gege Jiang, Guanfeng Xie, Xiaoyi Li, Jing Xiong

    Published 2025-06-01
    “…However, aberrant post-translational modifications (PTMs) in the MT binding domain—such as phosphorylation, acetylation and ubiquitination—trigger tau dissociation, causing microtubule collapse, transport deficits, and synaptic dysfunction. …”
    Get full text
    Article
  15. 175

    Role of the YWHAG gene mutations in Developmental and Epileptic Encephalopathy by Violet Vilmont, Richard S. Nowakowski, Yi Zhou

    Published 2025-08-01
    “…Specific missense mutations in the 14-3-3γ, such as Arg132Cys, significantly impair the protein’s binding affinity and are associated with a severe DEE. …”
    Get full text
    Article
  16. 176

    Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons by Beatrice Caballero, Scott J. Sherman, Torsten Falk

    Published 2017-01-01
    “…Vascular endothelial growth factor-B (VEGF-B), when initially discovered, was thought to be an angiogenic factor, due to its intimate sequence homology and receptor binding similarity to the prototype angiogenic factor, vascular endothelial growth factor-A (VEGF-A). …”
    Get full text
    Article
  17. 177
  18. 178
  19. 179

    Identification of novel compounds against Trypanosoma cruzi using AlphaFold structures by Albert Ros-Lucas, Alejandra Saeteros, Juan Carlos Gabaldón-Figueira, Nieves Martínez-Peinado, Elisa Escabia, Joaquim Gascón, Julio Alonso-Padilla

    Published 2025-01-01
    “…These compounds were predicted to target previously uncharacterized T. cruzi proteins, ledipasvir interacting with a calpain-like protein and pimecrolimus likely binding a mitotic cyclin. Molecular dynamics simulations showed that pimecrolimus remains stable in the predicted binding site, while ledipasvir exhibits a higher RMSD. …”
    Get full text
    Article
  20. 180

    Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage by Sandra Rayego-Mateos, Raul Rodrigues-Diez, Jose Luis Morgado-Pascual, Floris Valentijn, Jose M. Valdivielso, Roel Goldschmeding, Marta Ruiz-Ortega

    Published 2018-01-01
    “…This growth factor, by binding to EGFR and downstream signaling pathway activation, regulates renal inflammation, cell growth, and fibrosis. …”
    Get full text
    Article